# Lonza Biologics Plc – FDA Inspection, Jun 24, 2016

Source: https://www.keypedia.com/records/fda_inspections/lonza-biologics-plc/4cdfb86e-483c-4c1c-9222-982dd09ae126
Source feed: FDA_Inspections

> FDA inspection 978909 of Lonza Biologics Plc, June 24, 2016. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 978909
- Company Name: Lonza Biologics Plc
- Inspection Date: 2016-06-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1202907 - 2022-10-13
- [FDA Inspection 1070651 - 2018-09-28](https://www.keypedia.com/records/fda_inspections/lonza-biologics-plc/1bbabf2a-b092-4b45-8b6d-7f670d3b114e)
- FDA Inspection 1097017 - 2018-09-05
- [FDA Inspection 1021064 - 2017-03-31](https://www.keypedia.com/records/fda_inspections/lonza-biologics-plc/99bf7b21-6489-44e9-8ccb-b34c642e76c3)
- FDA Inspection 801062 - 2012-09-24

Company: https://www.keypedia.com/companies/lonza-biologics-plc/9bb3cb06-cade-452a-ba25-b43fec0aaa12

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c